Financial Gravity Companies’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Financial Gravity Companies's VRTX Position: Q2 2026 in Review
Financial Gravity Companies opened a new position in Vertex Pharmaceuticals (VRTX) in Q2 2026: 15 shares worth $7.45K. The stake represents ﹤0.01% of the portfolio and ranks #631 among its holdings. This is a return to the name: Financial Gravity Companies previously reported a position in VRTX as recently as Q4 2018.
Financial Gravity Companies first reported a position in VRTX in Q4 2017 and has held it in 4 quarters since. The position peaked at $206K in Q4 2018. 1,762 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Financial Gravity Companies held 15 shares of Vertex Pharmaceuticals worth $7.45K as of Q2 2026.
- Vertex Pharmaceuticals was a new Financial Gravity Companies position in Q2 2026.
- Vertex Pharmaceuticals made up ﹤0.01% of Financial Gravity Companies's portfolio in Q2 2026, its #631 holding.
- Financial Gravity Companies first reported a position in Vertex Pharmaceuticals in Q4 2017 and has held it in 4 quarters since.
- Financial Gravity Companies's Vertex Pharmaceuticals position peaked at $206K in Q4 2018.
- 1,762 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Financial Gravity Companies's 13F filing for Q2 2026, filed 5 Aug 2026.